These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7995358)

  • 21. Spores and soil from six sides: interdisciplinarity and the environmental biology of anthrax (Bacillus anthracis).
    Carlson CJ; Getz WM; Kausrud KL; Cizauskas CA; Blackburn JK; Bustos Carrillo FA; Colwell R; Easterday WR; Ganz HH; Kamath PL; Økstad OA; Turner WC; Kolstø AB; Stenseth NC
    Biol Rev Camb Philos Soc; 2018 Nov; 93(4):1813-1831. PubMed ID: 29732670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ecology of anthrax spores: tough but not invincible.
    Dragon DC; Rennie RP
    Can Vet J; 1995 May; 36(5):295-301. PubMed ID: 7773917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid and sensitive identification of pathogenic and apathogenic Bacillus anthracis by real-time PCR.
    Ellerbrok H; Nattermann H; Ozel M; Beutin L; Appel B; Pauli G
    FEMS Microbiol Lett; 2002 Aug; 214(1):51-9. PubMed ID: 12204372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fate of germinated Bacillus anthracis spores in primary murine macrophages.
    Guidi-Rontani C; Levy M; Ohayon H; Mock M
    Mol Microbiol; 2001 Nov; 42(4):931-8. PubMed ID: 11737637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence plasmid stability in environmentally occurring Bacillus anthracis from North East Turkey.
    Cooper C; Buyuk F; Schelkle B; Saglam AG; Celik E; Celebi O; Sahin M; Hawkyard T; Baillie L
    Antonie Van Leeuwenhoek; 2017 Jan; 110(1):167-170. PubMed ID: 27646562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic recommendations for the management of patients exposed to Bacillus anthracis in natural settings. SPILF. Société de pathologie infectieuse de langue franc¸aise .
    Piroth L; Leroy J; Rogeaux O; Stahl JP; Mock M; Garin-Bastuji B; Madani N; Brezillon C; Mailles A; May TH; SPILF
    Med Mal Infect; 2011 Nov; 41(11):567-78. PubMed ID: 21420809
    [No Abstract]   [Full Text] [Related]  

  • 28. Anthrax toxins.
    Duesbery NS; Vande Woude GF
    Cell Mol Life Sci; 1999 Sep; 55(12):1599-609. PubMed ID: 10526577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basis for the extraordinary genetic stability of anthrax.
    Kiel JL; Parker JE; Gifford H; Stribling LJ; Alls JL; Meltz ML; McCreary RP; Holwitt EA
    Ann N Y Acad Sci; 2002 Oct; 969():112-8. PubMed ID: 12381574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counting deadly spores.
    Comarow A
    US News World Rep; 2001 Nov; 131(20):22-3. PubMed ID: 11715866
    [No Abstract]   [Full Text] [Related]  

  • 31. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
    Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiologic questions from anthrax outbreak, Hunter Valley, Australia.
    Durrheim DN; Freeman P; Roth I; Hornitzky M
    Emerg Infect Dis; 2009 May; 15(5):840-2. PubMed ID: 19402992
    [No Abstract]   [Full Text] [Related]  

  • 33. Bacillus anthracis, a story of nature subverted by man.
    Baillie LW
    Lett Appl Microbiol; 2005; 41(3):227-9. PubMed ID: 16108911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HtrA is a major virulence determinant of Bacillus anthracis.
    Chitlaru T; Zaide G; Ehrlich S; Inbar I; Cohen O; Shafferman A
    Mol Microbiol; 2011 Sep; 81(6):1542-59. PubMed ID: 21801240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal dynamics in microbial soil communities at anthrax carcass sites.
    Valseth K; Nesbø CL; Easterday WR; Turner WC; Olsen JS; Stenseth NC; Haverkamp THA
    BMC Microbiol; 2017 Sep; 17(1):206. PubMed ID: 28950879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The characteristics of the interaction of Bacillus anthracis with host phagocytes in relation to the plasmid spectrum of the causative agent].
    Popov SF; Lipnitskiĭ AV; Barkov AM; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):13-6. PubMed ID: 8701646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
    BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The anthrax bacterium--a biological masterpiece with deadly potential].
    Myhre EB
    Lakartidningen; 2002 Feb; 99(6):484-7. PubMed ID: 11881219
    [No Abstract]   [Full Text] [Related]  

  • 40. Learning from the 2001 anthrax attacks: immunological characteristics.
    Hadler JL
    J Infect Dis; 2007 Jan; 195(2):163-4. PubMed ID: 17191158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.